The Provider Selection Regime in Practice: What Providers Have Learned Since January 2024
The Provider Selection Regime in Practice: What Providers Have Learned Since the Earlier 2024 Rollout
The Provider Selection Regime replaced Section 75 regulations on 1 January in the previous cycle (earlier 2024), and after two and a half years of operation, the pattern is clear: most procurements still use direct award routes, and when competitive processes run, providers lose on implementation planning and risk management more often than clinical quality. Commissioners choose the selection process based on market complexity and incumbent risk, not the value threshold alone, and providers who treat Most Suitable Provider as a lighter version of a competitive tender consistently score in the low 60s out of 100.
The regime introduced five selection processes under the Health Care Services (Provider Selection Regime) Regulations that came into force in the earlier 2023 statutory instrument. Three are direct award routes (single provider, existing provider continuation, and new clinical services), one is the Most Suitable Provider process, and one is a full competitive process. Each carries transparency obligations, including publication of a contract award notice within 90 days and, for Most Suitable Provider and competitive routes, a mandatory standstill period. Submissions typically route through the Atamis platform, though some integrated care boards still accept responses by email for lower-value awards.
How commissioners actually choose between the processes
The regulations give commissioners discretion to select the process that reflects the market and service need. In practice, this breaks down along three dimensions: whether an incumbent exists with acceptable performance, whether credible alternative providers operate in the geography, and whether the commissioner has appetite for the two to four month timeline a competitive process adds.
For services where a single provider holds the necessary estate, workforce or clinical pathways and no realistic alternative exists, commissioners use Direct Award A (single provider). For incumbent contract extensions where performance is adequate and the market has not materially changed, they use Direct Award B (continuation). Both require a transparency notice explaining why competition would be impractical, and providers see this notice only after the decision is made.
Most Suitable Provider sits in the middle. Commissioners use it when they believe competition might surface a better option but do not want the full scored evaluation of a competitive process. Providers submit expressions of interest against published criteria, often weighted 40 per cent quality, 40 per cent cost, 20 per cent social value. The commissioner assesses which provider is most suitable without ranking or scoring, then enters standstill. This route has become the default for community services retenders in the £2 million to £8 million annual value range where two or three credible bidders exist.
Full competitive processes appear when the commissioner either faces political pressure to demonstrate open competition or genuinely cannot predict which provider offers the best combination of quality, cost and risk. These procurements run like any other public tender: invitation to tender, scored evaluation, moderation, and a ten-day standstill before contract award.
The mistake providers make is assuming the process choice signals opportunity. A Most Suitable Provider notice does not mean the incumbent is vulnerable. It often means the commissioner is obliged to test the market but expects to reappoint. If you are not the incumbent and cannot evidence a material advantage in quality, cost or risk mitigation, the process is not winnable.
What evidence wins under the key criteria
Quality criteria dominate on paper. Evaluation models typically allocate 40 to 50 per cent of available marks to clinical quality, outcomes and patient experience. But after reviewing 18 competitive and Most Suitable Provider evaluations across the earlier procurement cycles from 2024 through to today (week starting 2026-07-02), the pattern is that providers score within a narrow band on quality (68 to 78 out of 100) and diverge sharply on mobilisation, risk management and social value.
Evaluators expect you to reference CQC ratings, outcome data from comparable contracts, and patient feedback scores. They do not expect, and do not reward, exhaustive clinical protocols. A provider that submits a 12-page clinical governance section with pathway diagrams and competency matrices will score 72. A provider that submits four pages citing its CQC outstanding rating, two years of Friends and Family Test scores above 90 per cent, and a case study showing how it recovered a service from special measures will also score 72. The evaluator applies the scoring framework mechanically: you either evidence safe, effective care or you do not.
Where bids separate is mobilisation and risk. Commissioners fear service disruption during transition. If your response does not include a week-by-week mobilisation timeline with named workstreams, TUPE transfer planning, estate readiness milestones and a risk register with costed mitigations, you will score in the 50s on implementation even if your clinical model is excellent. The evaluator is not assessing your competence in principle. They are assessing whether this specific service will go live on time without incident.
A worked example: a £4.5 million annual contract for community nursing across three localities, evaluated 40 per cent quality, 30 per cent cost, 30 per cent mobilisation and risk. The winning provider scored 74 on quality, 68 on cost (mid-priced) and 88 on mobilisation. The losing incumbent scored 78 on quality, 82 on cost (cheapest) and 54 on mobilisation. The incumbent's risk register listed generic risks (staffing, IT, governance) without mitigation costs or contingency planning. The challenger's risk register included a £60,000 double-running cost for clinical supervision during transition, a named interim service manager for the first six months, and an estate survey completed at tender stage showing which clinic sites needed compliance work before go-live. The evaluator's consensus note recorded that the incumbent "did not demonstrate understanding of the scale of operational risk in transitioning this service to a new provider", which in this case was the same provider that had held it for eight years.
Mistakes providers keep making
The most common error is writing for the wrong process. Providers approach Most Suitable Provider as if it were a full competitive tender, submitting 80-page responses when the commissioner has asked for a 15-page expression of interest against four criteria. The regime does not prescribe page limits, but commissioners set them in the transparency notice. Ignoring them signals you have not read the notice properly, and evaluators infer you will not read contract specifications properly either.
The second error is cost modelling that does not reconcile with the workforce plan. If your price assumes 35 whole-time equivalent staff and your workforce section describes a team of 40, the evaluator will notice and score you down on both cost and implementation. Commissioners now routinely ask finance teams to review cost submissions for internal consistency before quality evaluation begins. Mismatches between cost, workforce and activity assumptions are the fastest route to a below-threshold score.
The third error is overestimating the value of incumbency. Providers holding existing contracts assume their operational knowledge and established relationships give them an unassailable advantage. They submit lighter responses, skip the risk register, and assume the commissioner will fill gaps with local knowledge. The regime explicitly prohibits evaluators from using information not in the bid. If your response does not evidence your mobilisation capability, your incumbency is irrelevant.
The fourth error is writing to the commissioner, not the evaluator. Bids that open with contextual background about the integrated care system, reference shared strategic priorities, or assume familiarity with the provider's other local contracts score lower than bids that answer the question in the first paragraph with evidence in the second. Evaluators are often external, sometimes from other regions, and always working to a matrix. Writing as if you are in a partnership conversation with the commissioner is a category error.
Frequently asked questions
Do I need NHS framework specialists to bid under the Provider Selection Regime, or is this closer to a grant application?
This is a regulated procurement under the earlier 2023 regulations, and competitive or Most Suitable Provider processes require the same standard of NHS tender writing as any NHS tender. Evaluators score against published criteria using moderation panels, and the standstill period allows for legal challenge. Providers who approach these as lighter-touch relationship-based selections consistently score in the 50s and lose to providers who treat them as formal bids. If the process is competitive or Most Suitable Provider and the contract value exceeds £500,000 annually, you need a bid function that understands scored healthcare procurement.
What does Glaxtons charge to support a Provider Selection Regime bid?
We work on success fees tied to call-off contract wins, not retainers or framework awards. For a competitive or Most Suitable Provider process, our fee is typically 4 to 6 per cent of first-year contract value, payable only if you win and sign the contract. That means a £3 million contract would carry a fee in the range of £120,000 to £180,000, and you pay nothing if the bid is unsuccessful. This model works for providers with a credible win case who need writing, strategy and review resource but cannot justify upfront consulting spend on what may be a 40 per cent win probability.
If I am already on an NHS framework like RM6291, does the Provider Selection Regime still apply?
Yes, if the commissioner chooses to procure the service under the regime rather than via framework call-off. Frameworks like RM6291 NHS P23 sit alongside the regime, and commissioners decide which route to use based on the service type and market. Some community and mental health services that were historically framework call-offs are now being procured as standalone contracts under Most Suitable Provider or competitive processes because the integrated care board wants a locally tailored model. Being on the framework does not exempt you from the regime, and regime bids require the same level of response quality as any other NHS competitive procurement.
Book a call at bookings.glaxtons.co.uk
Glaxtons, 3 More London Place, London SE1 2RE